Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00497133
Recruitment Status : Completed
First Posted : July 6, 2007
Last Update Posted : June 4, 2008
Novo Nordisk A/S
The Danish Diabetes Association
Information provided by:
University of Copenhagen

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : March 2008